.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Argus Health
Daiichi Sankyo
McKesson
Chinese Patent Office
Teva
Colorcon
Novartis
Accenture
US Army

Generated: July 21, 2017

DrugPatentWatch Database Preview

CYCLOCORT Drug Profile

« Back to Dashboard

What is the patent landscape for Cyclocort, and when can generic versions of Cyclocort launch?

Cyclocort is a drug marketed by Astellas and is included in three NDAs.

The generic ingredient in CYCLOCORT is amcinonide. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amcinonide profile page.

Summary for Tradename: CYCLOCORT

Patents:0
Applicants:1
NDAs:3
Bulk Api Vendors: see list20
Patent Applications: see list2,873
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CYCLOCORT at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astellas
CYCLOCORT
amcinonide
CREAM;TOPICAL018116-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Astellas
CYCLOCORT
amcinonide
OINTMENT;TOPICAL018498-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Astellas
CYCLOCORT
amcinonide
CREAM;TOPICAL018116-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Astellas
CYCLOCORT
amcinonide
LOTION;TOPICAL019729-001Jun 13, 1988DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CYCLOCORT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astellas
CYCLOCORT
amcinonide
CREAM;TOPICAL018116-002Approved Prior to Jan 1, 19824,158,055► Subscribe
Astellas
CYCLOCORT
amcinonide
OINTMENT;TOPICAL018498-001Approved Prior to Jan 1, 19824,158,055► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Mallinckrodt
Novartis
Cerilliant
Dow
Colorcon
Healthtrust
McKinsey
Federal Trade Commission
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot